- Home
- STEM vs ACHV Comparison
STEM vs ACHV Comparison
Compare STEM & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- ACHV
- Stock Information
- Founded
- STEM 2009
- ACHV N/A
- Country
- STEM United States
- ACHV United States
- Employees
- STEM N/A
- ACHV N/A
- Industry
- STEM Computer Software: Prepackaged Software
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- STEM Technology
- ACHV Health Care
- Exchange
- STEM Nasdaq
- ACHV Nasdaq
- Market Cap
- STEM 126.2M
- ACHV 131.2M
- IPO Year
- STEM N/A
- ACHV N/A
- Fundamental
- Price
- STEM $14.87
- ACHV $2.55
- Analyst Decision
- STEM Hold
- ACHV Strong Buy
- Analyst Count
- STEM 7
- ACHV 3
- Target Price
- STEM $10.00
- ACHV $14.33
- AVG Volume (30 Days)
- STEM 784.5K
- ACHV 666.0K
- Earning Date
- STEM 08-07-2025
- ACHV 08-07-2025
- Dividend Yield
- STEM N/A
- ACHV N/A
- EPS Growth
- STEM N/A
- ACHV N/A
- EPS
- STEM N/A
- ACHV N/A
- Revenue
- STEM $156,002,000.00
- ACHV N/A
- Revenue This Year
- STEM $5.06
- ACHV N/A
- Revenue Next Year
- STEM $19.03
- ACHV N/A
- P/E Ratio
- STEM N/A
- ACHV N/A
- Revenue Growth
- STEM N/A
- ACHV N/A
- 52 Week Low
- STEM $5.81
- ACHV $1.84
- 52 Week High
- STEM $33.60
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- STEM 58.03
- ACHV 46.32
- Support Level
- STEM $11.14
- ACHV $2.37
- Resistance Level
- STEM $15.35
- ACHV $2.56
- Average True Range (ATR)
- STEM 1.55
- ACHV 0.12
- MACD
- STEM -0.01
- ACHV 0.01
- Stochastic Oscillator
- STEM 51.21
- ACHV 47.37
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.